51
|
Zhang Y, Wen J, Alamgir M, Xie J, Jing H, Fang M, Wang J, Zhang M, Meng Z, Yang L, Tao J. Impact of the COVID-19 pandemic on inpatient dermatology: a multicentre study from Hubei, China. J Eur Acad Dermatol Venereol 2020; 35:e179-e181. [PMID: 33220091 PMCID: PMC7753773 DOI: 10.1111/jdv.17041] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
52
|
Selvatici R, Fang M, Falzarano M, Gualandi F, Delin S, Bensemmane S, Shatillo A, Bello L, Pegoraro E, Ferlini A. NEW GENES AND DISEASES / NGS & RELATED TECHNIQUES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
53
|
Wang SH, Huan Q, Wang WH, Fang M, Zhao ZH. [Non-obstructive hypertrophic cardiomyopathy complicating with apical aneurysm: a case report]. ZHONGHUA XIN XUE GUAN BING ZA ZHI 2020; 48:788-791. [PMID: 32957765 DOI: 10.3760/cma.j.cn112148-20200719-00570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
|
54
|
Wang W, Xu C, Lei L, Wang D, Pu X, Zhu Y, Huang J, Yu Z, Li J, Fang Y, Wang H, Zhuang W, Lan S, Cai X, Zhang Y, Gao W, Wang L, Fang M, Lv T, Song Y. 1336P Patients with EGFR exon 20 insertion mutation non-small cell lung cancer benefit from pemetrexed-based chemotherapy: A multicenter study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
55
|
Diaz A, He H, Pavel A, Lefferdink R, Fang M, Canter T, Rangel S, Krueger J, Paller A, Guttman-Yassky E. 253 RNA-seq profiling of tape strips from infants with atopic dermatitis show profound barrier and immune abnormalities. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
56
|
Jin J, Xu Y, Hu X, Chen M, Fang M, Hang Q, Chen M. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer. ACTA ACUST UNITED AC 2020; 27:e283-e293. [PMID: 32669935 DOI: 10.3747/co.27.5899] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Background In this research, we used the mediastinal lymph node reclassification proposed by the International Association for the Study of Lung Cancer (iaslc) to screen for patients with pathologic N2 (pN2) non-small-cell lung cancer (nsclc) who might benefit from postoperative radiotherapy (port). Methods The study enrolled 440 patients with pN2 nsclc who received complete surgical resection and allocated them to one of three groups: N2a1 (single-station skip mediastinal lymph node metastasis), N2a2 (single-station non-skip mediastinal lymph node metastasis), and N2b (multi-station mediastinal lymph node metastasis). Rates of local recurrence at first recurrence in patients receiving and not receiving port were compared using the chi-square test. Overall (os) and disease-free survival (dfs) were then compared using Kaplan-Meier survival analysis with log-rank test. In addition, the factors potentially influencing os and dfs were analyzed using univariate and multivariate Cox regression. Results The rate of local recurrence for the N2a2 and N2b groups was significantly lower in patients receiving port (p = 0.044 and p = 0.043 respectively). The log-rank test revealed that, for the N2a1 group, differences in os and dfs were not statistically significant between the patients who did and did not receive port (p = 0.304 and p = 0.197 respectively). For the N2a2 group, os and dfs were markedly superior in patients who received port compared with those who did not (p = 0.001 and p = 0.014 respectively). For the N2b group, os was evidently better in patients who received port compared with those who did not (p = 0.025), but no statistically significant difference in dfs was observed (p = 0.134). Multivariate regression analysis revealed that, in the N2a1 group, port was significantly associated with poor os [hazard ratio (hr): 2.618; 95% confidence interval (ci): 1.185 to 5.785; p = 0.017]; in the N2a2 group, port was associated with improved os (hr: 0.481; 95% ci: 0.314 to 0.736; p = 0.001) and dfs (hr: 0.685; 95% ci: 0.479 to 0.980; p = 0.039). Conclusions For patients with pN2 nsclc who receive complete resection, port might be beneficial only for patients with single-station non-skip metastasis (N2a2). Patients with single-station skip metastasis (N2a1) and multi-station metastasis (N2b) might not currently benefit from port.
Collapse
|
57
|
Lin P, Zhu S, Huang Y, Li L, Tao J, Lei T, Song J, Liu D, Chen L, Shi Y, Jiang S, Liu Q, Xie J, Chen H, Duan Y, Xia Y, Zhou Y, Mei Y, Zhou X, Wu J, Fang M, Meng Z, Li H. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol 2020; 183:190-192. [PMID: 32255197 PMCID: PMC7262186 DOI: 10.1111/bjd.19089] [Citation(s) in RCA: 120] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
58
|
Fang M, Black K, Yang Z, Ohman-Strickland P, Graber J, Kipen H, Estrella B, Zarbl H. Alteration of NAD+-SIRT1 pathway as biomarkers of circadian disruption in shift workers. Sleep Med 2019. [DOI: 10.1016/j.sleep.2019.11.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
59
|
Chen X, Fang M. Oxidative stress mediated mitochondrial damage plays roles in pathogenesis of diabetic nephropathy rat. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2019; 22:5248-5254. [PMID: 30178848 DOI: 10.26355/eurrev_201808_15723] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Diabetic nephropathy (DN) is considered as a complication of diabetes and accounts for about 40%. Reactive oxygen species (ROS) level continues to increase in DN. However, whether specific ROS levels can alleviate renal damage by improving mitochondrial function has not been investigated. MATERIALS AND METHODS DN model was established by intraperitoneal injection of streptozotocin (STZ). The rats were divided into normal group, STZ model group, and N-acetylcysteine (NAC) group. Fasting blood glucose was tested to assess the modeling. The renal injury was evaluated by using hematoxylin-eosin (HE) staining and periodate-Schiff staining. Serum creatinine and 24 h urinary protein levels were determined by renal function detection kit. The levels of ROS and malondialdehyde (MDA) were assessed by the kit to evaluate the effects of oxidative stress and NAC in rats. The mitochondrial damage marker Cyto C level was detected by Western blot. RESULTS Blood glucose, serum creatinine, and urinary protein levels were significantly increased in model group compared with the normal group (p<0.05). Blood glucose levels, serum creatinine, and urinary protein levels were markedly improved after the ROS and MDA levels reduced by NAC. Meanwhile, glomerular hypertrophy, mesangial matrix accumulation, and severe renal injury were observed in the model group. NAC administration markedly improved glomerular morphology and mesangial matrix aggregation. Cyto C expression in the model group increased significantly compared with normal control group (p<0.05), while NAC effectively inhibited Cyto C levels. CONCLUSIONS Oxidative stress-mediated mitochondrial damage is an important part of the pathogenesis of DN. Inhibition of ROS production can be a potential target for DN treatment.
Collapse
|
60
|
Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. JAK3 defines a unique molecular subtypes of East Asian non-small cell lung cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz413.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
61
|
Shen Y, Fang S, Cai X, Fang Y, Lin R, Zhang Y, Li J, Liang X, Wang L, Lin L, Zhang L, Feng H, Lan S, Cai X, Xu C, Wang W, Fang M, Zhang J. Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz431.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
62
|
Li X, Wang W, Xu C, Pu X, Fang S, Cai X, Fang Y, Zhu Y, Wang H, Liang X, Zhuang W, Zhang Y, Wang L, Cai X, Li J, Feng H, Fang M, Chen G, Lv T, Song Y. A multicenter study of NRG1 fusions in Chinese non-small cell lung cancer patients and response to afatinib using next generation sequencing. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz437.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
63
|
Zhang Z, Zhang T, Cao L, Wang X, Cao J, Huang X, Cai Y, Lin Z, Pan H, Yuan Q, Fang M, Li S, Zhang J, Xia N, Zhao Q. Simultaneous in situ visualization and quantitation of dual antigens adsorbed on adjuvants using high content analysis. Nanomedicine (Lond) 2019; 14:2535-2548. [PMID: 31603382 DOI: 10.2217/nnm-2019-0016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Aim: Traditional antigenicity assay requires antigen recovery from the particulate adjuvants prior to analysis. An in situ method was developed for interrogating vaccine antigens with monoclonal antibodies while being adsorbed on adjuvants. Materials & methods: The fluorescence imaging-based high content analysis was used to visualize the antigen distribution on adjuvant agglomerates and to analyze the antigenicity for adsorbed antigens. Results: Simultaneous visualization and quantitation were achieved for dual antigens in a bivalent human papillomavirus vaccine with uniquely labeled antibodies. Good agreement was observed between the in situ multiplexed assays with well-established sandwich enzyme-linked immunosorbent assays. Conclusion: The streamlined procedures and the amenability for multiplexing make the in situ antigenicity analysis a favorable choice for in vitro functional assessment of bionanoparticles as vaccine antigens.
Collapse
|
64
|
Yu X, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Y, Chen G, Fang M, Lv T, Song Y. EP1.03-01 Molecular Spectrum of Patients with JAK1 Mutations in East Asian Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
65
|
Wang H, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. EP1.03-03 Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
66
|
Wang L, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. EP1.03-18 Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
67
|
Zhang Y, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. P1.03-35 Analysis of TET2 Gene Aberrations in East Asian Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
68
|
Lin C, Wang W, Zhu Y, Du K, Wang W, Xu C, Fang M. EP1.16-23 The Efficacy of S-1 in the Third or More Than Line Treatment of Advanced Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
69
|
Li X, Xu C, Xu S, Wang W, Ye J, Zhu Y, Ge T, Fang M, Lv T, Song Y. EP1.14-45 ROS1-ADGRG6: A Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
70
|
Yang D, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. EP1.03-14 Clinicopathologic Characteristics and Outcomes of Chinese Patients with Non-Small-Cell Lung Cancer and INPP4B Mutations. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
71
|
Wan B, Xu C, Wang W, Zhang X, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. EP1.03-19 The Frequency and Prognosis of MDM2 Mutations in East Asian Non-Small-Cell Lung Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
72
|
Falzarano M, Spedicato N, Margutti A, El Dani R, Rossi R, Gualandi F, Selvatici R, Fang M, Lu Z, Zia S, Reschiglian P, Roda B, Grilli A, Bicciato S, Ferlini A. P.134Physical and transcriptional characterization of human urinary stem cell populations. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
73
|
Wang W, Xu C, Zhang Q, Zhuang W, Zhu Y, Huang Y, Chen G, Fang M, Lv T, Song Y. EP1.03-07 Prevalence and Clinicopathological Characteristics of EIF1AX Mutations in Chinese Patients with Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
74
|
Li J, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Z, Chen G, Fang M, Lv T, Song Y. EP1.03-13 Molecular Characteristics of East Asian Patients with VHL-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
75
|
Ke H, Xu C, Wang W, Zhang Q, Zhuang W, Zhu Y, Huang Y, Chen G, Fang M, Lv T, Song Y. EP1.03-17 Outcomes of Molecular Characteristics in Chinese BAP1-Mutant Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|